| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C080755 |
3-(2-methoxybenzylamino)-2-phenylpiperidine |
3-(2-methoxybenzylamino)-2-phenylpiperidine inhibits the reaction [TAC1 protein results in increased expression of TACR1 mRNA] | decreases reaction|increases expression | 18441096
|
| C080755 |
3-(2-methoxybenzylamino)-2-phenylpiperidine |
3-(2-methoxybenzylamino)-2-phenylpiperidine binds to and results in decreased activity of TACR1 protein | affects binding|decreases activity | 18441096
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TACR1 mRNA | affects expression | 16483693
|
| D003913 |
Dextroamphetamine |
TACR1 protein affects the susceptibility to Dextroamphetamine | affects response to substance | 11897087
|
| C114556 |
aprepitant |
aprepitant inhibits the reaction [TAC1 protein results in increased expression of TACR1 mRNA] | decreases reaction|increases expression | 18441096
|
| C114556 |
aprepitant |
aprepitant binds to and results in decreased activity of TACR1 protein | affects binding|decreases activity | 18441096
|
| C015001 |
arsenite |
[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of TACR1 mRNA | affects cotreatment|decreases expression | 15894712
|
| C015001 |
arsenite |
arsenite results in decreased expression of TACR1 mRNA | decreases expression | 15894712
|
| D001564 |
Benzo(a)pyrene |
[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of TACR1 mRNA | affects cotreatment|decreases expression | 15894712
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of TACR1 mRNA | decreases expression | 15894712
|
| D002211 |
Capsaicin |
Capsaicin results in decreased expression of TACR1 mRNA | decreases expression | 18441096
|
| D002211 |
Capsaicin |
Capsaicin results in decreased expression of TACR1 protein | decreases expression | 18441096
|
| D004051 |
Diethylhexyl Phthalate |
Diethylhexyl Phthalate results in increased expression of TACR1 mRNA | increases expression | 15620428
|
| D004394 |
Dydrogesterone |
Dydrogesterone results in decreased expression of TACR1 protein | decreases expression | 16389545
|
| D019833 |
Genistein |
Genistein inhibits the reaction [CALCA protein results in increased expression of TACR1 mRNA] | decreases reaction|increases expression | 16777450
|
| D019833 |
Genistein |
Genistein inhibits the reaction [CALCA protein results in increased expression of TACR1 protein] | decreases reaction|increases expression | 16777450
|
| D006851 |
Hydrochloric Acid |
TACR1 affects the susceptibility to Hydrochloric Acid | affects response to substance | 12212954
|
| D006851 |
Hydrochloric Acid |
TACR1 protein affects the susceptibility to Hydrochloric Acid | affects response to substance | 11730984
|
| C076851 |
L 703606 |
L 703606 binds to and results in decreased activity of TACR1 protein | affects binding|decreases activity | 18364471
|
| D008345 |
Manganese |
Manganese results in decreased expression of TACR1 mRNA | decreases expression | 17175027
|
| C025340 |
manganese chloride |
manganese chloride results in decreased expression of TACR1 mRNA | decreases expression | 17175027
|
| C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [CALCA protein results in increased expression of TACR1 mRNA] | decreases reaction|increases expression | 16777450
|
| C063509 |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [CALCA protein results in increased expression of TACR1 protein] | decreases reaction|increases expression | 16777450
|
| C502587 |
(N-N'-bis-(2-(1H-indol-3-yl)-ethyl)-N,N'-bis-(3-thiomorpholin-4-yl-propyl)-phthalamide) |
(N-N'-bis-(2-(1H-indol-3-yl)-ethyl)-N,N'-bis-(3-thiomorpholin-4-yl-propyl)-phthalamide) binds to TACR1 protein | affects binding | 15925360
|
| D010100 |
Oxygen |
TACR1 protein results in increased susceptibility to Oxygen | increases response to substance | 11463606
|
| D010126 |
Ozone |
Ozone results in increased expression of TACR1 mRNA | increases expression | 16777450
|
| C025299 |
polyphenols |
polyphenols results in decreased expression of TACR1 mRNA | decreases expression | 16293270
|
| C071693 |
RP 67580 |
RP 67580 binds to and results in decreased activity of TACR1 protein | affects binding|decreases activity | 17056641
|
| C071693 |
RP 67580 |
RP 67580 binds to and results in decreased activity of TACR1 protein | affects binding|decreases activity | 18364471
|
| C071693 |
RP 67580 |
RP 67580 results in decreased activity of TACR1 protein | decreases activity | 17056641
|
| C054724 |
senktide |
senktide binds to and results in increased activity of TACR1 protein | affects binding|increases activity | 11245602
|
| C017947 |
sodium arsenite |
sodium arsenite results in increased activity of TACR1 protein | increases activity | 17056641
|
| C085215 |
SR 140333 |
SR 140333 binds to and results in decreased activity of TACR1 protein | affects binding|decreases activity | 9219603 11245602 9179376
|
| C085215 |
SR 140333 |
SR 140333 binds to and results in decreased activity of TACR1 protein | affects binding|decreases activity | 14585802
|
| C526005 |
SR140333B |
SR140333B binds to and results in decreased activity of TACR1 protein | affects binding|decreases activity | 16788306
|
| C105686 |
SU 5402 |
SU 5402 inhibits the reaction [FGF2 protein results in increased expression of TACR1 mRNA alternative form] | decreases reaction|increases expression | 16154193
|
| C105686 |
SU 5402 |
SU 5402 inhibits the reaction [TNF protein results in increased expression of TACR1 mRNA alternative form] | decreases reaction|increases expression | 16154193
|
| C105686 |
SU 5402 |
SU 5402 results in decreased expression of TACR1 mRNA alternative form | decreases expression | 16154193
|
| D013654 |
Taurine |
Taurine results in decreased expression of TACR1 mRNA | decreases expression | 16579726
|
| D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of TACR1 mRNA | decreases expression | 12807426
|
| C017967 |
W 7 |
W 7 inhibits the reaction [CALCA protein results in increased expression of TACR1 mRNA] | decreases reaction|increases expression | 16777450
|
| C017967 |
W 7 |
W 7 inhibits the reaction [CALCA protein results in increased expression of TACR1 protein] | decreases reaction|increases expression | 16777450
|
| D015054 |
Zymosan |
Zymosan affects the localization of TACR1 protein | affects localization | 17257769
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Capsaicin |
13.05 | 18926900 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Diethylhexyl Phthalate |
13.05 | 6734493 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
13.05 | 8875741 |
| MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.69 | 19490988 |
| MESH:D000033 |
Abortion, Threatened |
|
Dydrogesterone |
6.89 | 15760377 |
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
9.85 | 18287403 |
| MESH:D000138 |
Acidosis |
|
Hydrochloric Acid |
9.85 | 16144966 19262391 15920416 20872349 12771618 11574821 |
| MESH:D000141 |
Acidosis, Renal Tubular |
|
Hydrochloric Acid |
5.51 | 17183249 |
| MESH:D000142 |
Acidosis, Respiratory |
|
Hydrochloric Acid |
5.55 | 20597076 |
| MESH:D058186 |
Acute Kidney Injury |
|
Capsaicin |
4.31 | 18460982 |
| MESH:D055371 |
Acute Lung Injury |
|
Hydrochloric Acid |
9.03 | 19060228 15970105 11850527 11953099 19094174 16759491 19760209 |
| MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
9.03 | 16759491 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.19 | 20127859 20464547 |
| MESH:D000230 |
Adenocarcinoma |
|
Genistein |
4.19 | 11473722 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.50 | 6695378 |
| MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.43 | 15276417 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.64 | 17306315 16712894 |
| MESH:D000437 |
Alcoholism |
marker/mechanism |
|
| 19204064 |
| MESH:D000505 |
Alopecia |
|
Capsaicin |
4.52 | 17569567 |
| MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.38 | 15513908 |
| MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.97 | 17688650 |
| MESH:D000740 |
Anemia |
|
Zymosan |
4.33 | 18664788 |
| MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
10.25 | 16910769 |
| MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
10.25 | 16910769 |
| MESH:D000860 |
Anoxia |
|
Hydrochloric Acid |
10.74 | 15090967 |
| MESH:D000860 |
Anoxia |
|
Oxygen |
10.74 | 20872349 |
| MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.37 | 17497229 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.82 | 19183758 |
| MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
3.96 | 16872482 17659584 15944321 15142272 15188379 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.50 | 15570426 |
| MESH:D001249 |
Asthma |
|
Ozone |
2.56 | 16373670 17854713 |
| MESH:D050197 |
Atherosclerosis |
|
Oxygen |
3.65 | 16391483 |
| MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
marker/mechanism |
|
| 19204064 |
| MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.03 | 18985861 17688650 20603192 16609825 18558336 18775368 15238991 17507914 18940202 19232924 17157402 19460635 18177632 18396377 18316065 |
| MESH:D001714 |
Bipolar Disorder |
marker/mechanism |
|
| 19204064 |
| MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.94 | 20046352 17594078 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Hydrochloric Acid |
4.58 | 15920416 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.24 | 8888407 |
| MESH:D001919 |
Bradycardia |
|
Capsaicin |
4.79 | 18207255 |
| MESH:D002545 |
Brain Ischemia |
|
Capsaicin |
4.71 | 19211983 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.05 | 20146248 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Genistein |
2.05 | 16873071 16541309 17200150 |
| MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
2.05 | 17263869 |
| MESH:D016535 |
Bronchial Hyperreactivity |
|
Hydrochloric Acid |
8.25 | 12378975 |
| MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
8.25 | 15516495 17626835 18315731 16777450 19059883 14754758 18417511 |
| MESH:D001986 |
Bronchial Spasm |
|
Hydrochloric Acid |
5.20 | 15578804 |
| MESH:D002100 |
Cachexia |
|
Ozone |
4.48 | 16183385 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
3.05 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.05 | 15276417 17306315 16507464 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.34 | 20419170 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.34 | 18572023 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.13 | 16332659 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
2.81 | 19524636 20056578 |
| MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.61 | 20734317 |
| MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
5.67 | 15037631 |
| MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
5.67 | 17182828 |
| MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
5.67 | 16293270 |
| MESH:D003371 |
Cough |
|
Capsaicin |
4.91 | 10350223 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.88 | 8888407 17688650 16575769 |
| MESH:D003556 |
Cystitis |
|
Hydrochloric Acid |
5.20 | 19279288 20719367 12853844 12599022 |
| MESH:D018856 |
Cystitis, Interstitial |
|
Hydrochloric Acid |
5.55 | 17714534 |
| MESH:D003876 |
Dermatitis, Atopic |
|
Diethylhexyl Phthalate |
3.93 | 16882537 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
2.42 | 16647724 |
| MESH:D058065 |
Diabetic Cardiomyopathies |
|
Taurine |
5.79 | 16025228 |
| MESH:D003967 |
Diarrhea |
|
SR 140333 |
5.63 | 9219603 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
6.10 | 19370779 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Taurine |
6.10 | 9328219 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.10 | 19641884 1733752 |
| MESH:D004381 |
Duodenal Ulcer |
|
Capsaicin |
4.44 | 10671773 11535926 |
| MESH:D004417 |
Dyspnea |
|
Oxygen |
4.57 | 20016425 |
| MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.81 | 1851702 |
| MESH:D004487 |
Edema |
|
Zymosan |
3.76 | 7907874 |
| MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.33 | 16402032 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
3.19 | 11473722 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.90 | 3659116 17275665 |
| MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.65 | 16628512 3922381 |
| MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.80 | 20417680 18234410 |
| MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.37 | 7562514 6254150 6426943 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.04 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.80 | 3659116 |
| MESH:D004935 |
Esophageal Diseases |
|
Capsaicin |
12.62 | 19566590 |
| MESH:D004935 |
Esophageal Diseases |
|
Hydrochloric Acid |
12.62 | 19566590 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.94 | 16530937 |
| MESH:D004941 |
Esophagitis |
|
Hydrochloric Acid |
5.73 | 12928072 |
| MESH:D004942 |
Esophagitis, Peptic |
|
Hydrochloric Acid |
5.75 | 20516732 14621274 11346197 |
| MESH:D005234 |
Fatty Liver |
|
arsenite |
7.32 | 18296743 |
| MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
7.32 | 19224547 14986274 |
| MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.62 | 16575769 |
| MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.88 | 8888407 18558336 |
| MESH:D005355 |
Fibrosis |
|
arsenite |
8.62 | 18296743 |
| MESH:D005355 |
Fibrosis |
|
Hydrochloric Acid |
8.62 | 18497604 |
| MESH:D005739 |
Gas Poisoning |
|
Hydrochloric Acid |
11.31 | 12378975 |
| MESH:D005739 |
Gas Poisoning |
|
Oxygen |
11.31 | 20016425 |
| MESH:D005764 |
Gastroesophageal Reflux |
|
Hydrochloric Acid |
5.08 | 19957777 19951613 20516732 12212954 20616304 20545468 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.42 | 16452187 |
| MESH:D005909 |
Glioblastoma |
|
Capsaicin |
11.18 | 18405923 |
| MESH:D005909 |
Glioblastoma |
|
Genistein |
11.18 | 16598420 |
| MESH:D005909 |
Glioblastoma |
|
Manganese |
11.18 | 17043766 |
| MESH:D006356 |
Heartburn |
|
Capsaicin |
12.62 | 19566590 |
| MESH:D006356 |
Heartburn |
|
Hydrochloric Acid |
12.62 | 19566590 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.52 | 20471113 |
| MESH:D006505 |
Hepatitis |
|
Zymosan |
4.45 | 19110552 |
| MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.94 | 12676792 |
| MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.60 | 17688650 |
| MESH:D006930 |
Hyperalgesia |
|
Capsaicin |
4.12 | 17043245 17434803 |
| MESH:D006940 |
Hyperemia |
|
Hydrochloric Acid |
5.39 | 12646421 |
| MESH:D006975 |
Hypertension, Portal |
|
Hydrochloric Acid |
5.09 | 16984587 |
| MESH:D006976 |
Hypertension, Pulmonary |
|
Hydrochloric Acid |
4.27 | 19262391 |
| MESH:D007022 |
Hypotension |
|
Hydrochloric Acid |
4.52 | 11574821 |
| MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.82 | 12646999 15346721 |
| MESH:D007249 |
Inflammation |
|
Capsaicin |
11.04 | 16956363 |
| MESH:D007249 |
Inflammation |
|
Hydrochloric Acid |
11.04 | 11574821 |
| MESH:D007249 |
Inflammation |
|
polyphenols |
11.04 | 16366677 |
| MESH:D007249 |
Inflammation |
|
Zymosan |
11.04 | 8014878 11289658 |
| MESH:D007410 |
Intestinal Diseases |
|
Hydrochloric Acid |
4.71 | 11574821 |
| MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.57 | 17553498 |
| MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.65 | 20008137 |
| MESH:D007818 |
Laryngeal Diseases |
|
Hydrochloric Acid |
6.09 | 16498863 |
| MESH:D007826 |
Laryngismus |
|
Hydrochloric Acid |
6.09 | 11510729 |
| MESH:D007938 |
Leukemia |
|
Genistein |
2.89 | 18980019 17468513 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.11 | 17596541 16294345 |
| MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
6.81 | 18296743 |
| MESH:D008103 |
Liver Cirrhosis |
|
Hydrochloric Acid |
6.81 | 16984587 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
3.06 | 17823541 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Taurine |
3.06 | 15931870 15893842 |
| MESH:D008107 |
Liver Diseases |
|
Capsaicin |
4.52 | 16956363 |
| MESH:D008107 |
Liver Diseases |
|
polyphenols |
4.52 | 16698588 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.03 | 20195826 21137059 |
| MESH:D008113 |
Liver Neoplasms |
|
Diethylhexyl Phthalate |
7.03 | 11940454 |
| MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.03 | 15276417 16712894 |
| MESH:D008171 |
Lung Diseases |
|
Hydrochloric Acid |
11.51 | 16784557 |
| MESH:D008171 |
Lung Diseases |
|
Ozone |
11.51 | 19066396 8266340 |
| MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
11.51 | 19095001 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.00 | 17228818 |
| MESH:D055370 |
Lung Injury |
|
Hydrochloric Acid |
13.92 | 19262391 16129981 18497604 20597076 21311175 15090967 11395602 18573544 18339021 17627322 15607125 15044056 19644408 21114838 |
| MESH:D055370 |
Lung Injury |
|
Oxygen |
13.92 | 18339021 |
| MESH:D055370 |
Lung Injury |
|
Ozone |
13.92 | 20417186 |
| MESH:D008175 |
Lung Neoplasms |
|
arsenite |
4.62 | 16809336 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.62 | 6695378 20464547 20135361 18520028 18816296 17053015 18569708 20869020 20064080 |
| MESH:D008175 |
Lung Neoplasms |
|
Ozone |
4.62 | 7614698 8597069 |
| MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.62 | 17306315 15276417 17077188 19931552 16712894 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
2.78 | 14578162 12929590 |
| MESH:D020149 |
Manganese Poisoning |
|
Manganese |
5.25 | 19453300 16551646 16568477 |
| MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.00 | 16487513 19082730 |
| MESH:D008679 |
Metaplasia |
|
Ozone |
4.84 | 10496685 |
| MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.01 | 18803445 18765137 |
| MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.25 | 1613127 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.99 | 16381670 |
| MESH:D009069 |
Movement Disorders |
|
Manganese |
4.77 | 16551646 |
| MESH:D009101 |
Multiple Myeloma |
|
Capsaicin |
3.97 | 17505005 |
| MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.96 | 12879239 12130978 10890648 18160304 15241586 17724436 15259001 15213630 15834315 10479408 |
| MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.79 | 8888407 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.01 | 17596541 |
| MESH:D009203 |
Myocardial Infarction |
|
Genistein |
5.92 | 17141266 |
| MESH:D009203 |
Myocardial Infarction |
|
Hydrochloric Acid |
5.92 | 18534312 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
3.46 | 17141266 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.59 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.59 | 11559025 |
| MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.41 | 20056578 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.15 | 15738583 |
| MESH:D009410 |
Nerve Degeneration |
|
Manganese |
4.08 | 16551646 |
| MESH:D009421 |
Nervous System Malformations |
|
Genistein |
3.78 | 16427766 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.77 | 12854658 |
| MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
6.77 | 16359493 8888407 |
| MESH:D020078 |
Neurogenic Inflammation |
marker/mechanism |
|
| 17257769 |
| MESH:D020078 |
Neurogenic Inflammation |
|
Capsaicin |
4.85 | 17961222 |
| MESH:D009765 |
Obesity |
|
Capsaicin |
3.33 | 19056576 |
| MESH:D009784 |
Occupational Diseases |
|
Hydrochloric Acid |
4.54 | 12378975 |
| MESH:D010024 |
Osteoporosis |
|
Genistein |
3.09 | 19401787 |
| MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
3.84 | 16169203 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
4.69 | 19005980 |
| MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.69 | 17306315 15276417 |
| MESH:D010146 |
Pain |
|
Capsaicin |
3.81 | 18987195 17434803 19081190 16996476 17084039 17043245 |
| MESH:D010300 |
Parkinson Disease |
|
Manganese |
3.28 | 11181820 |
| MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.24 | 16140633 |
| MESH:D010538 |
Peritonitis |
|
Ozone |
9.55 | 16369182 |
| MESH:D010538 |
Peritonitis |
|
Zymosan |
9.55 | 14761945 15259001 17826846 17371808 18977430 19088179 11985352 18557954 15979727 18760300 19641140 |
| MESH:D011014 |
Pneumonia |
|
Ozone |
4.13 | 18381685 18007984 18929643 |
| MESH:D011015 |
Pneumonia, Aspiration |
|
Hydrochloric Acid |
5.11 | 18573544 15970105 18497604 15607125 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
3.57 | 20603192 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.65 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.65 | 16925846 15378649 15256057 |
| MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.65 | 16039940 |
| MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.27 | 11422049 12752131 |
| MESH:D001261 |
Pulmonary Atelectasis |
|
Hydrochloric Acid |
5.75 | 20597076 |
| MESH:D011654 |
Pulmonary Edema |
|
Hydrochloric Acid |
4.95 | 15090967 |
| MESH:D015427 |
Reperfusion Injury |
|
Capsaicin |
3.83 | 18460982 19211983 |
| MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Hydrochloric Acid |
8.95 | 18339021 18549715 16129981 16784557 17627322 |
| MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
8.95 | 18339021 17627322 |
| MESH:D012133 |
Respiratory Paralysis |
|
Hydrochloric Acid |
6.09 | 11510729 |
| MESH:D012140 |
Respiratory Tract Diseases |
|
Hydrochloric Acid |
4.90 | 20516732 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.93 | 19155313 |
| MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.03 | 19110320 15737665 |
| MESH:D012640 |
Seizures |
|
Valproic Acid |
2.57 | 1511512 3137016 17978042 11044598 11738929 14763951 16876388 15475178 |
| MESH:D018805 |
Sepsis |
|
Zymosan |
4.44 | 11441115 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.30 | 10029692 19755658 |
| MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.30 | 18572023 19524636 |
| MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.88 | 12854658 |
| MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.88 | 19490988 |
| MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.27 | 12833885 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.55 | 20155912 2093021 |
| MESH:D013276 |
Stomach Ulcer |
|
Hydrochloric Acid |
4.00 | 16755016 17189318 15309881 |
| MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
5.28 | 12563064 |
| MESH:D013705 |
Temporomandibular Joint Disorders |
|
Capsaicin |
12.47 | 17997062 |
| MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
12.47 | 17997062 |
| MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.97 | 17262798 |
| MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.26 | 3119515 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
4.70 | 17053015 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
4.70 | 16712894 11723127 17306315 16452187 |
| MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.38 | 8888407 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.54 | 11813266 |
| MESH:D014605 |
Uveitis |
|
Zymosan |
5.13 | 11006244 |
| MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.16 | 17056641 |